Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2356 | 3923 | 27.6 | 46% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
7188 | 1318 | ILOPROST//WESTERN INFIRM SURG//TAPROSTENE |
10841 | 962 | CARBACYCLIN//CARBACYCLINS//SM 10906 |
14274 | 714 | MED BIOCHEM KURAMOTO CHO//4 ACETOXY 2 4 METHYLPHENYLBENZOTHIAZOLE//PHARMACEUT S KITA KU |
23226 | 298 | PROSTACYCLIN STIMULATING FACTOR//CANINE PLATELET//CELLULAR METABOLITES |
27742 | 182 | I EM NEURODEGENERAT BRAIN//BERAPROST SODIUM//NEONATE INFANT PATHOL |
28906 | 161 | 11 SEIRYO MACHIAOBA KU//PSYCHOLOGIC TREATMENT//METHIONIN ENKEPHALIN |
32733 | 103 | PREVU POC SKIN STEROL TEST//SKIN TISSUE CHOLESTEROL//ATHEROSCLEROSIS REVERSAL CLIN |
32792 | 102 | PLASMA RECALCIFICATION//TAIL BLEEDING TIME//RAT PLATELET |
33902 | 83 | IBUDILAST//CAS 50847 11 5//221 MIYAMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | I EM NEURODEGENERAT BRAIN | Address | 21 | 78% | 0% | 14 |
2 | BERAPROST SODIUM | Author keyword | 14 | 40% | 1% | 27 |
3 | IBUDILAST | Author keyword | 14 | 47% | 1% | 22 |
4 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | Journal | 12 | 11% | 3% | 99 |
5 | ILOPROST | Author keyword | 9 | 14% | 2% | 63 |
6 | PROSTACYCLIN ANALOG | Author keyword | 7 | 41% | 0% | 13 |
7 | WESTERN INFIRM SURG | Address | 6 | 80% | 0% | 4 |
8 | CARBACYCLIN | Author keyword | 6 | 58% | 0% | 7 |
9 | TAPROSTENE | Author keyword | 6 | 58% | 0% | 7 |
10 | BERAPROST | Author keyword | 5 | 27% | 0% | 17 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BERAPROST SODIUM | 14 | 40% | 1% | 27 | Search BERAPROST+SODIUM | Search BERAPROST+SODIUM |
2 | IBUDILAST | 14 | 47% | 1% | 22 | Search IBUDILAST | Search IBUDILAST |
3 | ILOPROST | 9 | 14% | 2% | 63 | Search ILOPROST | Search ILOPROST |
4 | PROSTACYCLIN ANALOG | 7 | 41% | 0% | 13 | Search PROSTACYCLIN+ANALOG | Search PROSTACYCLIN+ANALOG |
5 | CARBACYCLIN | 6 | 58% | 0% | 7 | Search CARBACYCLIN | Search CARBACYCLIN |
6 | TAPROSTENE | 6 | 58% | 0% | 7 | Search TAPROSTENE | Search TAPROSTENE |
7 | BERAPROST | 5 | 27% | 0% | 17 | Search BERAPROST | Search BERAPROST |
8 | CARBACYCLINS | 3 | 100% | 0% | 3 | Search CARBACYCLINS | Search CARBACYCLINS |
9 | POSTISCHEMIC DEMENTIA | 3 | 100% | 0% | 3 | Search POSTISCHEMIC+DEMENTIA | Search POSTISCHEMIC+DEMENTIA |
10 | SM 10906 | 3 | 100% | 0% | 3 | Search SM+10906 | Search SM+10906 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 2 3 DINOR THROMBOXANE B2 | 41 | 100% | 0% | 15 |
2 | TRK 100 | 24 | 60% | 1% | 26 |
3 | KC 404 | 21 | 73% | 0% | 16 |
4 | ZK 36 374 | 21 | 90% | 0% | 9 |
5 | POTENT CARBON ANALOG | 20 | 100% | 0% | 9 |
6 | ISOCARBACYCLIN | 19 | 76% | 0% | 13 |
7 | STABLE PROSTACYCLIN ANALOG | 19 | 40% | 1% | 36 |
8 | 11 DEHYDRO TXB2 | 13 | 80% | 0% | 8 |
9 | 11 DEHYDROTHROMBOXANE B2 | 12 | 48% | 0% | 19 |
10 | PGI2 | 11 | 26% | 1% | 38 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 12 | 11% | 3% | 99 |
2 | PROSTAGLANDINS AND MEDICINE | 5 | 14% | 1% | 32 |
3 | EICOSANOIDS | 2 | 12% | 0% | 15 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
SYNTHESIS OF THERAPEUTICALLY USEFUL PROSTAGLANDIN AND PROSTACYCLIN ANALOGS | 1993 | 244 | 104 | 67% |
ILOPROST - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN PERIPHERAL VASCULAR-DISEASE, MYOCARDIAL-ISCHEMIA AND EXTRACORPOREAL-CIRCULATION PROCEDURES | 1992 | 185 | 126 | 67% |
Recent developments in the synthesis of prostaglandins and analogues | 2007 | 81 | 209 | 28% |
Prostanoids for critical limb ischaemia | 2010 | 18 | 35 | 60% |
Analysis of eicosanoids by LC-MS/MS and GC-MS/MS: A historical retrospect and a discussion | 2014 | 8 | 56 | 25% |
Application of gas chromatography mass spectrometry and gas chromatography tandem mass spectrometry to assess in vivo synthesis of prostaglandins, thromboxane, leukotrienes, isoprostanes and related compounds in humans | 1998 | 88 | 236 | 36% |
Sporadic Alzheimer's Disease Begins as Episodes of Brain Ischemia and Ischemically Dysregulated Alzheimer's Disease Genes | 2013 | 14 | 154 | 19% |
Gas Chromatographic Determination of Prostaglandins | 2002 | 14 | 70 | 69% |
Fully stereocontrolled total syntheses of the prostacyclin analogues 16S-iloprost and 16S-3-oxa-iloprost by a common route, using alkenylcopper-azoalkene conjugate addition, asymmetric olefination, and allylic alkylation | 2005 | 24 | 76 | 36% |
Ibudilast: A non-selective PDE inhibitor with multiple actions on blood cells and the vascular wall | 2001 | 34 | 29 | 31% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | I EM NEURODEGENERAT BRAIN | 21 | 78% | 0.4% | 14 |
2 | WESTERN INFIRM SURG | 6 | 80% | 0.1% | 4 |
3 | NEONATE INFANT PATHOL | 4 | 67% | 0.1% | 4 |
4 | HLTH SCI INTERNAL MED CARDIOVASC | 4 | 75% | 0.1% | 3 |
5 | MED BIOCHEM KURAMOTO CHO | 3 | 100% | 0.1% | 3 |
6 | PHARMACEUT S KITA KU | 2 | 67% | 0.1% | 2 |
7 | BIOMED 432 ASAHIGAOKA | 1 | 100% | 0.1% | 2 |
8 | JEFFERSON MED PHYSIOL 1020 LOCUST ST | 1 | 50% | 0.1% | 2 |
9 | MED MED MED CLIN PHARMACOL | 1 | 100% | 0.1% | 2 |
10 | SERV READ TAT VASC | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000022921 | CYCLOOXYGENASE 2//COX 2//CYCLOOXYGENASE |
2 | 0.0000015675 | 5 LIPOXYGENASE//EXPT THER EUT REPERFUS INJURY//LEUKOTRIENES |
3 | 0.0000013539 | CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE |
4 | 0.0000011239 | PULMONARY MICROCIRCULATION//PRESSURE FLOW PLOTS//CHRONIC INSTRUMENTATION |
5 | 0.0000011034 | CITICOLINE//CLORICROMENE//CDP CHOLINE |
6 | 0.0000010236 | NITRATE TOLERANCE//NITROGLYCERIN//ORGANIC NITRATES |
7 | 0.0000009359 | CARDIOPLEGIA//JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY//CARIPORIDE |
8 | 0.0000007558 | NSAIDS//NABUMETONE//ROFECOXIB |
9 | 0.0000006883 | GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO |
10 | 0.0000006383 | CICLETANINE//TIROPRAMIDE//MUSANGA CECROPIOIDES |